货号:A171923 同义名: 盐酸洛哌丁胺 / R-18553 hydrochloride;Loperamide (hydrochloride)
Loperamide HCl is a potent and selective μ-opioid receptor agonist.
There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | Opioid receptor ↓ ↑ | ORL1 ↓ ↑ | μ-opioid receptor ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Racecadotril | ✔ | 98% | |||||||||||||||||
JTC-801 |
++
Opioid receptor-like1 (ORL1), IC50: 94 nM |
98% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | Loperamide (Hydrochloride) is an opioid receptor agonist widely used for the treatment of diarrhea[3]. In contrast with other opioid agonists, loperamide is a peripherally acting μ-receptor agonist exerting its effects mainly on the myenteric plexus of the gastrointestinal longitudinal muscle layer. It decreases peristalsis and fluid secretion resulting in longer gastrointestinal transit time. The bioavailability of the drug is extremely low. Moreover, it is actively excluded from the central nervous system; hence, it lacks the central effects of euphoria and analgesia at the recommended dosages[4]. Rats were orally gavaged with 1.5, 3, or 6 mg/kg body weight (BW) of loperamide hydrochloride for 7 days. The results after 7 days administration of loperamide, revealed dose-dependent increase in aspartate aminotransferase, lactate dehydrogenase, creatine kinase-MB, and serum concentration of cardiac troponin I, total homocysteine, and nitric oxide. Loperamide provoked cardiotoxicity through oxidative stress, lipid peroxidation, and DNA fragmentation in rats[5]. Loperamide decreased cell viability in a dose-dependent fashion and was most effective against canine osteosarcoma cells. When co-incubated with doxorubicin, loperamide induced a synergistic cell kill in canine carcinoma cells[6]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT03575078 | Lymphoma | Phase 1 | Not yet recruiting | August 23, 2023 | - |
NCT00555620 | - | Completed | - | - | |
NCT02677844 | - | Completed | - | - | |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.95mL 0.39mL 0.19mL |
9.74mL 1.95mL 0.97mL |
19.47mL 3.89mL 1.95mL |
CAS号 | 34552-83-5 |
分子式 | C29H34Cl2N2O2 |
分子量 | 513.499 |
别名 | 盐酸洛哌丁胺 ;R-18553 hydrochloride;Loperamide (hydrochloride);R 18553;PJ 185;NSC 696356;Loperamide hydrochloride |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Inert atmosphere,Room Temperature |
溶解度 |
DMSO: 50 mg/mL(97.37 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 1 mg/mL(1.95 mM),配合低频超声助溶 |
动物实验配方 |
2% DMSO+30% PEG 300+water 2.5 mg/mL |
Tags: Loperamide | 34552-83-5 | R-18553 | R18553 | R 18553 | Opioid Receptor Agonist | GPCR/G Protein | Neuronal Signaling | Autophagy | Opioid Receptor | Autophagy | 仅供科研使用 | AmBeed-信号通路专用抑制剂 | Loperamide HCl 纯度/质量文件 | Loperamide HCl 亚型比较 | Loperamide HCl 生物活性 | Loperamide HCl 临床数据 | Loperamide HCl 参考文献 | Loperamide HCl 实验方案 | Loperamide HCl 技术信息
请填写此表格索取QC报告。我们很快就会发送到您的邮箱。您的信息在我们这里是安全的。*是必填项.
靶点 | 数值 |
需要的总药量: mg
您需要配制的工作液浓度为:mg/mL
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT03575078 | Lymphoma | Phase 1 | Not yet recruiting | August 23, 2023 | - |
NCT00555620 | - | Completed | - | - | |
NCT02677844 | - | Completed | - | - | |
NCT02677844 | Healthy | Phase 1 | Completed | - | United States, Florida ... 展开 >> Covance Clinical Research Unit Daytona Beach, Florida, United States, 32117 United States, Indiana Covance Clinical Research Unit Evansville, Indiana, United States, 47710 收起 << |
NCT02125604 | Relapsing-Remitting Multiple S... 展开 >>clerosis 收起 << | Phase 4 | Completed | - | Germany ... 展开 >> Research Site Augsburg, Germany Research Site Bamburg, Germany Research Site Bayreuth, Germany Research Site Berlin, Germany Research Site Bochum, Germany Research Site Bonn, Germany Research Site Erbach, Germany Research Site Erlangen, Germany Research Site Freiburg, Germany Research Site Hamburg, Germany Research Site Leipzig, Germany Research Site Marburg, Germany Research Site Minden, Germany Research Site Mittweida, Germany Research Site Munchen, Germany Research Site Munster, Germany Research Site Osnabruck, Germany Research Site Potsdam, Germany Research Site Siegen, Germany 收起 << |
NCT02125604 | - | Completed | - | - | |
NCT00068588 | - | Completed | - | - | |
NCT02662855 | Ebola Virus Disease | Phase 2 | Completed | - | - |
NCT00068588 | Male Breast Cancer ... 展开 >> Recurrent Breast Cancer Stage IV Breast Cancer 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> University of California Davis Cancer Center Sacramento, California, United States, 95817 收起 << |
NCT00406653 | Crohn's Disease | Phase 3 | Terminated(Sponsor Decision) | - | - |
NCT00957580 | Leukemia, Myeloid, Acute ... 展开 >> Hematologic Neoplasms 收起 << | Phase 2 | Terminated(The trial has been ... 展开 >>terminated due to an estimated low probability of clinical benefit based on limited anti-leukemic effects observed in safety run-in (Part 1)) 收起 << | - | United States, Illinois ... 展开 >> Northwestern University Chicago, Illinois, United States United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States Dana Farber Cancer Institute Boston, Massachusetts, United States United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States France Hospital Hotel Dieu, Service D'Hematologie Nantes, Cedex, France Hospital Edouard Herriot, Service d'Hematologie Clinique Lyon Cedex, France Hospital Saint Louis, Service des Maladies du Sang Paris, France CHU du Haut-Leveque, Service des Maladies du Sang Unite de Recherche Clinique Pessac, France 收起 << |
NCT01406574 | Hepatocellular Carcinoma | Phase 1 Phase 2 | Completed | - | Japan ... 展开 >> Chiba, Japan Tokyo, Japan 收起 << |
NCT01317641 | - | Completed | - | - | |
NCT00957580 | - | Terminated(The trial has been ... 展开 >>terminated due to an estimated low probability of clinical benefit based on limited anti-leukemic effects observed in safety run-in (Part 1)) 收起 << | - | - | |
NCT00406653 | - | Terminated(Sponsor Decision) | - | - | |
NCT01406574 | - | Completed | - | - | |
NCT02204241 | Multiple Myeloma | Phase 1 Phase 2 | Active, not recruiting | June 2021 | Italy ... 展开 >> FO.NE.SA.Onlus Torino, Italy, 10126 收起 << |
NCT03542461 | Squamous Non-small Cell Lung C... 展开 >>ancer 收起 << | Phase 3 | Recruiting | September 30, 2022 | Italy ... 展开 >> UOC Oncologia - Azienda USL di Imola - Ospedale Santa Maria della Scaletta Recruiting Imola, Bologna, Italy Contact: Antonio Maestri, Dr. +390542662442 a.maestri@ausl.imola.bo.it Principal Investigator: Antonio Maestri Oncologia Medica - IRST - IRCCS di Meldola Recruiting Meldola, Forlì, Italy Contact: Angelo Delmonte, Dr. +390543739100 angelo.delmonte@irst.emr.it Principal Investigator: Angelo Delmonte AUSL 12 Viareggio, Ospedale Versilia, Lido di Camaiore (LU) - Oncologia Medica Recruiting Lido Di Camaiore, Lucca, Italy Contact: Andrea Camerini, Dr. +3905846057282 andreacamerini@katamail.com Principal Investigator: Andrea Camerini UO Medicina Oncologica - Ospedale di Carpi (MO) - Azienda USL di Modena Recruiting Carpi, Modena, Italy Contact: Lucia Longo, Dr. +39059659294 l.longo@ausl.mo.it Principal Investigator: Lucia Longo UOC di Oncologia Medica - Presidio Santa Croce Azienda Ospedaliera - Ospedale Riuniti Marche NORD Recruiting Fano, Pesaro-Urbino, Italy Contact: Paolo Lippe, Dr. +390721882396 paolippe@gmail.com Principal Investigator: Paolo Lippe UOC di Oncologia Medica - ASST Valle Olona - Presidio Ospedaliero di Saronno Recruiting Saronno, Varese, Italy Contact: Claudio Verusio, Dr. +39029613576 cverusio@aobusto.it Principal Investigator: Claudio Verusio UOC Oncologia Medica - Azienda ULSS21 di Legnago VR Recruiting Legnago, Verona, Italy Contact: Andrea Bonetti, Dr. +390442622801 andrea.bonetti@aulsslegnago.it Principal Investigator: Andrea Bonetti Oncologia Medica - Ospedale Sacro Cuore - Don Calabria Recruiting Negrar, Verona, Italy Contact: Stefania Gori, Dr. +390456013550 stefania.gori@sacrocuore.it Principal Investigator: Stefania Gori SC Oncologia - ASO "SS Antonio e Biagio e Cesare Arrigo" Recruiting Alessandria, Italy Contact: Pierluigi Piovano, Dr. +390131206753 plpiovano@ospedale.al.it Principal Investigator: Pierluigi Piovano U.O.C. di Oncologia Medica - Istituto Tumori "Giovanni Paolo II" I.R.C.C.S. Ospedale Oncologico di Bari Recruiting Bari, Italy Contact: Domenico Galetta, Dr. +390805555418 galetta@oncologico.bari.it Principal Investigator: Domenico Galetta Humanitas Gavazzeni - Cliniche Gavazzeni spa - Sezione Oncologia Pneumologica ed Urologica Recruiting Bergamo, Italy Contact: Giovanni Luca Ceresoli, Dr. +390354204760 giovanni_luca.ceresoli@gavazzeni.it Principal Investigator: Giovanni Luca Ceresoli UO Oncologia Medica - A.S.S.T. Papa Giovanni XXIII di Bergamo Recruiting Bergamo, Italy Contact: Anna Bettini, Dr. +390352674660 abettini@hpg23.it Principal Investigator: Anna Bettini UO di Oncologia Medica - Azienda Ospedaliero-Universitaria S. Orsola Malpighi Recruiting Bologna, Italy Contact: Andrea Ardizzoni, Dr +390512142204 andrea.ardizzoni@aosp.bo.it Principal Investigator: Andrea Ardizzoni, Dr UOC di Oncologia - Azienda USL di Bologna, Ospedale Bellaria Recruiting Bologna, Italy Contact: Alba Brandes, Dr. +390516225697 a.brandes@ausl.bo.it Principal Investigator: Alba Brandes Divisione di Oncologia Medica - Ospedale di Bolzano Recruiting Bolzano, Italy Contact: Emanuela Vattemi, Dr. +390471907490 emanuela.vattemi@asbz.it Principal Investigator: Emanuela Vattemi UOC Oncologia Medica - PO A.Perino ASL di Brindisi Recruiting Brindisi, Italy Contact: Saverio Cinieri, Dr. +390831537218 saverio.cinieri@ieo.it Principal Investigator: Saverio Cinieri Azienda Ospedaliero - Universitaria "Policlinico - Vittorio Emanuele" - P.O. "G. Rodolico" - Oncologia Medica Recruiting Catania, Italy Contact: Hector Soto Parra, Dr. +390953781496 hsotoparra@policlinico.unict.it Principal Investigator: Hector Soto Parra SC di Oncologia - Istituti Ospitalieri di Cremona Recruiting Cremona, Italy Contact: Matteo Brighenti, Dr. +390372405246 m.brighenti@asst-cremona.it Principal Investigator: Matteo Brighenti Dipartimento di Oncologia Medica - Azienda Ospedaliera S.Croce e Carle Cuneo - Ospedale Carle Recruiting Cuneo, Italy Contact: Ida Colantonio, Dr. +390171616753 oncologia@ospedale.cuneo.it Principal Investigator: Ida Colantonio UO di Oncologia Ematologia - Azienda Ospedaliero Universitaria di Ferrara Recruiting Ferrara, Italy Contact: Antonio Frassoldati, Dr. +390532239209 a.frassoldati@ospfe.it Principal Investigator: Antonio Frassoldati S.C. Oncologia Medica 1 - Azienda Ospedaliero Universitaria Careggi Recruiting Firenze, Italy Contact: Francesca Mazzoni, Dr. +390557949648 mazzonifr@aou-careggi.toscana.it Principal Investigator: Francesca Mazzoni UOS Tumori Polmonari - IRCCS AOU San Martino -IST- Istituto Nazionale per la Ricerca sul Cancro Recruiting Genova, Italy Contact: Francesco Grossi, Dr. +390105600658 francesco.grossi@hsanmartino.it Principal Investigator: Francesco Grossi Azienda USL Toscana nord ovest - Ospedale San Luca di Lucca - Dipartimento Oncologico Recruiting Lucca, Italy Contact: Edi Editta Baldini, Dr. +390583055748 editta.baldini@uslnordovest.toscana.it Principal Investigator: Edi Editta Baldini Azienda Ospedaliero-Universitaria di Modena - Policlinico - Dipartimento di Scienze Mediche e Chirurgiche, Materno Infantili e dell'adulto Recruiting Modena, Italy Contact: Fausto Barbieri, Dr. +390594224385 barbieri.fausto@policlinico.mo.it Principal Investigator: Fausto Barbieri SC di Oncologia Medica - A.O. San Gerardo Recruiting Monza, Italy Contact: Diego Cortinovis, Dr. +390392333683 d.cortinovis@asst-monza.it Principal Investigator: Diego Cortinovis S. C. di Oncologia Medica - AORN "Antonio Cardarelli" Not yet recruiting Napoli, Italy Contact: Giacomo Cartenì, Dr +390817472174 studiclinici@yahoo.it Principal Investigator: Giacomo Cartenì U.O.C Pneumologia ad Indirizzo Oncologico - AORN Ospedali dei Colli Monaldi Not yet recruiting Napoli, Italy Contact: Danilo Rocco, Dr. +390817062 clinicaltrialsrocco@gmail.com Principal Investigator: Danilo Rocco IOV Istituto Oncologico Veneto - UOC di Oncologia Medica 2 Recruiting Padova, Italy Contact: Giulia Pasello, Dr. +390498215620 giulia.pasello@ioveneto.it Principal Investigator: Giulia Pasello UOC di Oncologia Medica - Azienda Ospedaliero Universitaria di Parma Recruiting Parma, Italy Contact: Marcello Tiseo, Dr. +390521702316 mtiseo@ao.pr.it Principal Investigator: Marcello Tiseo S.C. di Oncologia Medica - Ospedale S.Maria della Misericordia Recruiting Perugia, Italy Contact: Rita Chiari, Dr. +390755784099 rita.chiari@unipg.it Principal Investigator: Rita Chiari AUSL - Piacenza - Ospedale "Guglielmo da Saliceto"-Dip.Oncologia e Ematologia- UO di Oncologia Medica Azienda Recruiting Piacenza, Italy Contact: Luigi Cavanna, Dr. +390523302697 l.cavanna@ausl.pc.it Principal Investigator: Luigi Cavanna Azienda Ospedaliera Universitaria Pisana - Dipartimento Medico in Oncologia Recruiting Pisa, Italy Contact: Enrico Vasile, Dr. +39050992451 envasile@tin.it Principal Investigator: Enrico Vasile Struttura Complessa di Oncologia - IRCCS - Arcispedale Santa Maria Nuova Recruiting Reggio Emilia, Italy Contact: Francesca Zanelli, Dr. +390522296628 Francesca.zanelli@asmn.re.it Principal Investigator: Francesca Zanelli AUSL della Romagna - Ambito di Rimini - Ospedale Infermi di Rimini - UO di Oncologia Recruiting Rimini, Italy Contact: Maximilian Papi, Dr. +390541705413 maximilian.papi@auslromagna.it Principal Investigator: Maximilian Papi Pneumologia ad Indirizzo Oncologico 1 - A.O. San Camillo Forlanini Recruiting Roma, Italy Contact: Rita Migliorino, Dr. +390658704670 mrmiglio53@gmail.com Principal Investigator: Rita Migliorino Università la Sapienza - Policlinico Umberto I - Dipartimento di scienze radiologiche, oncologiche e anatomo-patologiche - UOC Oncologia B Not yet recruiting Roma, Italy Contact: Enrico Cortesi, Dr. +39064450099 enrico.cortesi@uniroma1.it Principal Investigator: Enrico Cortesi UO Oncologia Medica - ASL N.1 di Sassari - Ospedale Civile di Sassari Recruiting Sassari, Italy Contact: Antonio Pazzola, Dr. +390792061534 antonio.pazzola@tiscali.it Principal Investigator: Antonio Pazzola U.O. Oncologia Medica - Ospedale Santa Chiara Recruiting Trento, Italy Contact: Matteo Bertolin, Dr. +390461902478 Matteo.Bertolin@apss.tn.it Principal Investigator: Matteo Bertolin Reparto di Oncologia - Azienda Sanitaria Universitaria Integrata di Udine - Presidio Ospedaliero Santa Maria della Misericordia Recruiting Udine, Italy Contact: Alessandro Follador, Dr. +390432559307 alessandro.follador@asuiud.sanita.fvg.it Principal Investigator: Alessandro Follador U.S.O. GIVOP (Gruppo Interdisciplinare Veronese Oncologia Polmonare) Oncologia - Azienda Ospedaliera Integrata Verona Recruiting Verona, Italy Contact: Antonio Santo, Dr. +390458123876 antonio.santo@ospedaleuniverona.it Principal Investigator: Antonio Santo 收起 << |
NCT01317641 | Prostate Cancer | Phase 1 Phase 2 | Completed | - | United States, Colorado ... 展开 >> The Urology Center of Colorado Wheat Ridge, Colorado, United States, 80211 United States, Connecticut Eastern CT Hematology and Oncology Associates Norwich, Connecticut, United States, 06360 United States, Florida Urology Health Team PLLC Ocala, Florida, United States, 34474 United States, Maryland Chesapeake Urology Research Associates Baltimore, Maryland, United States, 21327 United States, New Jersey Delaware Valley urology, LLC Voorhees, New Jersey, United States, 08043 United States, New York Brooklyn Urology Research Group Brooklyn, New York, United States, 11215 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, South Carolina Carolina Urologic Research Center Myrtle Beach, South Carolina, United States, 29572 Czech Republic Klinika onkologie a radioterapie LFUK a FN Hradec Králové, Czech Republic Fakultni Nemonicnice Olomouc Olomouc, Czech Republic Oddeleni Radiacni a Klinicke Onkologie Nemocnice Znojmo Znojmo, Czech Republic Estonia East-Tallinn Central Hospital Talinn, Estonia Finland Helsinki University Central Hospital Helsinki, Finland Kuopio University Hospital Kuopio, Finland Oulu University Hospital Oulu, Finland Tampere University Hospital Tampere, Finland Turku University Hospital Turku, Finland France Saint Louis Hospital Paris, France Institut Gustave Roussy Villejuif, France United Kingdom Queen Elizabeth Hospital Birmingham, United Kingdom Velindre Cancer Centre Cardiff, United Kingdom Christie Hospital Manchester, United Kingdom Churchill Hospital Oxford, United Kingdom 收起 << |
NCT02202200 | Melanoma BRAF V600E/K Mutated ... 展开 >> CDNKN2A Loss Defined 收起 << | Phase 1 Phase 2 | Unknown | August 2018 | France ... 展开 >> Saint-Louis Hospital Recruiting Paris, France, 75010 Contact: Celeste Lebbe, MDPHD +33 1 42 49 49 49 celeste.lebbe@sls.aphp.fr Principal Investigator: celeste lebbe, MD-PHD 收起 << |
NCT01787500 | Advanced Cancers | Phase 1 | Active, not recruiting | February 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02047162 | Diarrhea | Not Applicable | Completed | - | Pakistan ... 展开 >> HOPE Karachi, Pakistan 收起 << |
NCT03495167 | Myelodysplastic Syndrome | Phase 1 | Recruiting | June 2019 | Japan ... 展开 >> Research Site Recruiting Nagoya, Aichi, Japan Research Site Recruiting Maebashi, Gunma, Japan Research Site Recruiting Sapporo, Hokkaido, Japan Research Site Recruiting Kobe, Hyogo, Japan Research Site Recruiting Kurashiki, Okayama, Japan Research Site Recruiting Shinagawa, Tokyo, Japan Research Site Recruiting Fukuoka, Japan Research Site Recruiting Kumamoto, Japan Research Site Recruiting Kyoto, Japan 收起 << |
NCT01432886 | Breast Cancer | Phase 1 | Completed | - | Japan ... 展开 >> Kashiwa-shi, Chiba, Japan Hidaka-shi, Saitama, Japan 收起 << |
NCT01538537 | Advanced Cancer ... 展开 >> Solid Tumors Cancer Neoplasms 收起 << | Phase 1 | Completed | - | United States, New York ... 展开 >> Mount Sinai School of Medicine New York, New York, United States, 10029 收起 << |
NCT00398086 | Metastatic Pancreatic Cancer | Phase 1 Phase 2 | Completed | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham Comprehensive Cancer Ctr Birmingham, Alabama, United States United States, Arizona Scottsdale Healthcare/Virginia Pipe Cancer Institute Scottsdale, Arizona, United States, 85258 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Baltimore, Maryland, United States, 35233 United States, Minnesota Virigina Piper Cancer Institute Minneapolis, Minnesota, United States, 55407 United States, Texas South Texas Oncology & Hematology San Antonio, Texas, United States, 78258 收起 << |
NCT02379624 | Nutrition Disorders ... 展开 >> Critical Illness 收起 << | Phase 1 Phase 2 | Completed | - | - |
NCT00398086 | - | Completed | - | - | |
NCT03464136 | Crohn Disease | Phase 3 | Recruiting | October 22, 2020 | - |
NCT01344876 | Multiple Myeloma ... 展开 >> Non-Hodgkin Lymphoma Acute Myeloid Leukemia Acute Lymphoid Leukemia Chronic Myeloid Leukemia 收起 << | Phase 1 | Completed | - | Japan ... 展开 >> Nagoya, Japan Tokyo, Japan 收起 << |
NCT00280397 | - | Completed | - | - | |
NCT01432886 | - | Completed | - | - | |
NCT00047502 | Chronic Myelogenous Leukemia | Phase 1 | Completed | - | United States, Texas ... 展开 >> M.D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00280397 | Cancer: Solid Tumors | Phase 1 | Completed | - | Japan ... 展开 >> Tokyo, Japan, 104-0045 收起 << |
NCT02403310 | Leukemia Acut... 展开 >>e Myeloid Leukemia AML 收起 << | Phase 1 | Active, not recruiting | March 2019 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT00150462 | Waldenstrom's Macroglobulinemi... 展开 >>a Non-Hodgkin's Lymphoma Hodgkin's Disease Multiple Myeloma 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> Tower Cancer Research Foundation Beverly Hills, California, United States, 90211-1850 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Weil Medical College of Cornell University New York, New York, United States, 10021 Herbert Irving Comprehensive Cancer Center, Columbia University New York, New York, United States, 10032 收起 << |
NCT00150462 | - | Completed | - | - | |
NCT01837940 | Constipation ... 展开 >>Diarrhea Indigestion Reflux Abdominal Pain 收起 << | Phase 3 | Completed | - | Sweden ... 展开 >> Örebro University Örebro, Närke, Sweden, 701 82 收起 << |
NCT01926665 | Lymphoma | Phase 1 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01344876 | - | Completed | - | - | |
NCT01700335 | Myelodysplastic Syndrome | Phase 1 | Completed | - | Japan ... 展开 >> Research Site Nagoya, Aichi, Japan Research Site Fukuoka, Japan Research Site Tokyo, Japan 收起 << |
NCT03635112 | Crohn's Disease | Phase 2 | Recruiting | September 2020 | United States, Florida ... 展开 >> Theravance Biopharma Investigational Site Recruiting Aventura, Florida, United States, 33180 Theravance Biopharma Investigational Site Recruiting Clearwater, Florida, United States, 33765 Theravance Biopharma Investigational Site Recruiting Hialeah, Florida, United States, 33013 Theravance Biopharma Investigational Site Recruiting Largo, Florida, United States, 33777 Theravance Biopharma Investigational Site Recruiting Miami, Florida, United States, 33135 Theravance Biopharma Investigational Site Recruiting New Port Richey, Florida, United States, 34653 United States, Massachusetts Theravance Biopharma Investigational Site Recruiting Brockton, Massachusetts, United States, 02302 United States, Michigan Theravance Biopharma Investigational Site Recruiting Wyoming, Michigan, United States, 49519 United States, North Carolina PMG Research of Salisbury Recruiting Salisbury, North Carolina, United States, 28144 United States, Pennsylvania Theravance Biopharma Investigational Site Recruiting Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Theravance Biopharma Investigational Site Recruiting Houston, Texas, United States, 77058 Theravance Biopharma Investigational Site Recruiting San Antonio, Texas, United States, 78215 Theravance Biopharma Investigational Site Recruiting Spring, Texas, United States, 77386 United States, Virginia Theravance Biopharma Investigational Site Recruiting Lansdowne Town Center, Virginia, United States, 20176 收起 << |
NCT01700335 | - | Completed | - | - | |
NCT01297556 | Irritable Bowel Syndrome | Not Applicable | Unknown | December 2011 | United States, Michigan ... 展开 >> Michigan Gastroenterology Institute Not yet recruiting East Lansing, Michigan, United States, 48823 Contact: Iftiker Ahmad, M.D. 517-332-1200 ext 221 Principal Investigator: Iftiker Ahmad, M.D. 收起 << |
NCT00046917 | Unspecified Adult Solid Tumor,... 展开 >> Protocol Specific 收起 << | Phase 1 | Completed | - | United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT02309931 | Primary Malignant Neoplasm of ... 展开 >>Ascending Colon 收起 << | Not Applicable | Active, not recruiting | November 1, 2017 | Spain ... 展开 >> Hospital Universitario Virgen de La Arrixaca Murcia, Spain, 30120 收起 << |
NCT01369355 | - | Active, not recruiting | - | - | |
NCT02147574 | Constipation | Phase 4 | Completed | - | China, Heilongjiang ... 展开 >> The First Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China, 150000 收起 << |
NCT02667860 | Pain | Not Applicable | Recruiting | March 2018 | Spain ... 展开 >> Hospital de la Santa Creu i Sant Pau Recruiting Barcelona, Spain, 08025 Contact: Bollo Jesus, MD +34-639622465 jbollo@santpau.cat 收起 << |
NCT02837874 | Stomach Neoplasms | Not Applicable | Recruiting | March 2019 | Korea, Republic of ... 展开 >> Keimyung University Dongsan Medical Center Recruiting Daegu, Korea, Republic of, 700-712 Contact: Seung Wan Ryu, MD, PhD 82-53-250-7322 gsman@dsmc.or.kr Contact: In Gyu Kwon, MD 82-53-250-7322 surgeon@dsmc.or.kr Principal Investigator: Seung Wan Ryu, MD, PhD Sub-Investigator: In Gyu Kwon, MD Sub-Investigator: Young Gil Son, MD, PhD 收起 << |
NCT03372681 | Gastric Cancer ... 展开 >> Postoperative Complications 收起 << | Not Applicable | Not yet recruiting | December 31, 2022 | - |
NCT01369355 | Crohn's Disease ... 展开 >> Colitis IBD Inflammatory Bowel Disease 收起 << | Phase 3 | Active, not recruiting | October 21, 2019 | - |
NCT02877134 | Crohn Disease | Phase 2 | Recruiting | March 11, 2022 | - |
NCT00982865 | Solid Tumors ... 展开 >>Cancer 收起 << | Phase 1 | Completed | - | Australia ... 展开 >> Westmead Hospital Westmead, Australia Belgium Jules Bordet Institute Brussels, Belgium, B-1000 Ghent University Hospital Ghent, Belgium France Institute Bergonié Bordeaux, France Hôpital Beaujon Paris, France, 92118 Hopital Saint Louis Paris, France Centre Eugène Marquis Rennes, France Institute Claudius Regaud Toulouse, France, 03 31052 Netherlands Netherlands Cancer Institute - Antonie van Leeuwenhoek Hospital Amsterdam, Netherlands 收起 << |
NCT00982865 | - | Completed | - | - | |
NCT00080990 | Unspecified Adult Solid Tumor,... 展开 >> Protocol Specific 收起 << | Phase 1 | Completed | - | United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT02991768 | Diarrhea | Phase 2 | Recruiting | April 2019 | United States, Kansas ... 展开 >> University of Kansas Medical Center Recruiting Kansas City, Kansas, United States, 66160 收起 << |
NCT03352765 | Lymphoma | Phase 1 Phase 2 | Recruiting | November 2020 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Parastoo Dahi, MD 212-639-5846 Contact: Paul Hamlin, MD 908-542-3366 收起 << |
NCT00424632 | - | Completed | - | - | |
NCT00555620 | Stomach Neoplasms | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Pfizer Investigational Site Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Pfizer Investigational Site Goyang, Gyeonggi, Korea, Republic of, 410-769 Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 收起 << |
NCT00424632 | Solid Tumors | Phase 1 | Completed | - | United States, Tennessee ... 展开 >> Pfizer Investigational Site Nashville, Tennessee, United States, 37203 Belgium Pfizer Investigational Site Leuven, Belgium, 3000 收起 << |
NCT00932126 | Advanced Solid Tumors | Phase 1 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | United States, California ... 展开 >> Pfizer Investigational Site Santa Monica, California, United States, 90404 United States, Colorado Pfizer Investigational Site Aurora, Colorado, United States, 80045 Australia, Victoria Pfizer Investigational Site East Melbourne, Victoria, Australia, 3002 收起 << |
NCT00932126 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT01128387 | Cancer | Phase 1 Phase 2 | Terminated(slow accrual) | - | United States, Wisconsin ... 展开 >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 收起 << |
NCT01277666 | Crohn's Disease | Phase 3 | Completed | - | - |
NCT01128387 | - | Terminated(slow accrual) | - | - | |
NCT00584740 | Crohn's Disease | Phase 2 | Terminated(The study was termi... 展开 >>nated prematurely after futility criterion was met at planned interim analysis of 41 patients.) 收起 << | - | Germany ... 展开 >> Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Stuttgart, Germany, 70376 收起 << |
NCT01277666 | - | Completed | - | - | |
NCT01090011 | Carcinoma, Non-Small-Cell Lung | Phase 1 | Completed | - | United States, Colorado ... 展开 >> 1200.71.1004 Boehringer Ingelheim Investigational Site Aurora, Colorado, United States United States, Connecticut 1200.71.1003 Boehringer Ingelheim Investigational Site New Haven, Connecticut, United States United States, New York 1200.71.1001 Boehringer Ingelheim Investigational Site New York, New York, United States United States, Tennessee 1200.71.1002 Boehringer Ingelheim Investigational Site Nashville, Tennessee, United States Netherlands 1200.71.2002 Boehringer Ingelheim Investigational Site Amsterdam, Netherlands 1200.71.2001 Boehringer Ingelheim Investigational Site Groningen, Netherlands 收起 << |
NCT00584740 | - | Terminated(The study was termi... 展开 >>nated prematurely after futility criterion was met at planned interim analysis of 41 patients.) 收起 << | - | - | |
NCT01536418 | Crohn's Disease | Phase 3 | Terminated | - | - |
NCT01090011 | - | Completed | - | - | |
NCT01393899 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT01393626 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT01393626 | - | Completed | - | - | |
NCT03733314 | Crohn's Disease | Phase 2 | Recruiting | September 2021 | Japan ... 展开 >> E6011-ET2 Trial Site 4 Not yet recruiting Nagoya, Aichi, Japan E6011-ET2 Trial Site 10 Not yet recruiting Kashiwa, Chiba, Japan E6011-ET2 Trial Site 9 Not yet recruiting Ogaki, Gifu, Japan E6011-ET2 Trial Site 7 Not yet recruiting Nishinomiya, Hyogo, Japan E6011-ET2 Trial Site 8 Not yet recruiting Takamatsu, Kagawa, Japan E6011-ET2 Trial Site 2 Not yet recruiting Bunkyo, Tokyo, Japan E6011-ET2 Trial Site 3 Not yet recruiting Minato, Tokyo, Japan E6011-ET2 Trial Site 6 Not yet recruiting Mitakashi, Tokyo, Japan E6011-ET2 Trial Site 1 Not yet recruiting Shinjuku, Tokyo, Japan E6011-ET2 Trial Site 5 Recruiting Kagoshima, Japan 收起 << |
NCT00615199 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT01536418 | - | Terminated | - | - | |
NCT00011778 | Squamous Cell Carcinoma | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01393899 | - | Completed | - | - | |
NCT00842244 | Stomach Neoplasms ... 展开 >> Advanced Gastric Cancer 收起 << | Phase 1 | Completed | - | Japan ... 展开 >> Pfizer Investigational Site Kashiwa, Chiba, Japan Pfizer Investigational Site Yufu-city, Oita, Japan Korea, Republic of Pfizer Investigational Site Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Pfizer Investigational Site Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 收起 << |
NCT00461526 | Irritable Bowel Syndrome | Phase 2 | Completed | - | - |
NCT02771249 | Healthy Volunteers | Phase 1 | Recruiting | December 31, 2019 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov 收起 << |
NCT00615199 | - | Completed | - | - | |
NCT01166815 | Diarrhea Mala... 展开 >>ria 收起 << | Phase 2 Phase 3 | Completed | - | United States, Massachusetts ... 展开 >> U.S. Army Research Institute of Environmental Medicine (USARIEM) Natick, Massachusetts, United States, 01760 United States, North Dakota U.S. Department of Agriculture, Agricultural Research Service, Grand Forks Human Nutrition Center Grand Forks, North Dakota, United States, 56721 Kenya Kombewa Clinical Research Center Kombewa, Kisumu West, Kenya 收起 << |
NCT01922570 | Critical Illness | Not Applicable | Completed | - | Switzerland ... 展开 >> Service of Intensive Care Geneva, Switzerland, 1211 收起 << |
NCT02179580 | Irritable Bowel Syndrome | Phase 2 Phase 3 | Unknown | December 2015 | Taiwan ... 展开 >> China Medical University Hospital Recruiting Taichung, Taiwan Contact: HsuehChou Lai, MD 收起 << |
NCT03489265 | Fecal Incontinence ... 展开 >> Accidental Bowel Leakage Anal Incontinence Diarrhea Urge Incontinence 收起 << | Phase 2 | Not yet recruiting | March 2020 | United States, North Carolina ... 展开 >> University of North Carolina at Chapel Hill School of Dentistry Building Not yet recruiting Chapel Hill, North Carolina, United States, 27599-8080 收起 << |
NCT03722511 | Neuroendocrine Tumors ... 展开 >> Carcinoid Tumor of GI System Diarrhea Carcinoid Syndrome 收起 << | Phase 2 | Not yet recruiting | August 2030 | United States, Kentucky ... 展开 >> University of Kentucky Markey Cancer Center Not yet recruiting Lexington, Kentucky, United States, 40536 Contact: Cynthia Leedham, PhD Principal Investigator: Lowell Anthony, MD 收起 << |
NCT00281606 | HIV Infection | Phase 4 | Completed | - | United States, California ... 展开 >> UCI Irvine, California, United States, 92668 USC Los Angeles, California, United States, 90033 UCSD San Diego, California, United States, 92103 Santa Clara Valley Medical Center San Jose, California, United States, 95128 Harbor-UCLA Medical Center Torrance, California, United States, 90502 收起 << |
NCT02280759 | Acute Gastroenteritis | Phase 1 | Completed | - | Poland ... 展开 >> Department of Paediatrics, The Medical University of Warsaw, Poland Warsaw, Poland, 01-183 收起 << |
NCT00842244 | - | Completed | - | - | |
NCT01153854 | Diarrhea | Phase 3 | Completed | - | Mexico ... 展开 >> National Pediatric Institute Mexico city, Mexico, 04530 收起 << |
NCT03633344 | Diarrhoea;Acute | Phase 2 | Completed | - | - |
NCT02730741 | Antidiarrhoea | Phase 2 | Recruiting | - | France ... 展开 >> BIOSE Recruiting Aurillac, France Contact: NIVOLIEZ Mr Adrien +330471465101 a.nivoliez@biose.com Principal Investigator: Pr. Jacques MOREAU 收起 << |
NCT00359970 | Diarrhea | Phase 4 | Completed | - | Mexico ... 展开 >> University of Texas Enteric Disease Research Clinics Guadalajara, Jalisco, Mexico 收起 << |
NCT02018653 | Cancer Diarrh... 展开 >>ea 收起 << | Not Applicable | Terminated(Slow Accrual) | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00265122 | - | Completed | - | - | |
NCT00292344 | Travelers' Diarrhea | Phase 4 | Completed | - | Mexico ... 展开 >> Universidad Autonoma de Guadalajara Guadalajara, Jalisco, Mexico University of Arizona, Colegio Guadalajara Guadalajara, Jalisco, Mexico University of San Diego at Iteso Guadalajara, Jalisco, Mexico Clinica Londres Morelos Cuernavaca, Morelos, Mexico 收起 << |
NCT02517957 | Eczema | Phase 2 | Unknown | - | - |
NCT00265122 | Crohn Disease | Phase 2 | Completed | - | - |
NCT01476683 | Diarrhea | Phase 1 | Completed | - | Canada, Quebec ... 展开 >> Algorithme Pharma Inc. Mount-Royal, Quebec, Canada, H3P 3P1 收起 << |
NCT02819960 | Diarrhea Canc... 展开 >>er 收起 << | Phase 3 | Unknown | September 2018 | Slovakia ... 展开 >> National Cancer Institute Recruiting Bratislava, Slovakia, 833 10 Contact: Michal Mego, MD 00421904442530 misomego@gmail.com Contact: Lubos Drgona, MD 00421259 378 512 lubos.drgona@nou.sk 收起 << |
NCT02018653 | - | Terminated(Slow Accrual) | - | - | |
NCT02052583 | Cardiac Arrest | Not Applicable | Completed | - | France ... 展开 >> CH de Fréjus-Saint Raphael Fréjus, France, 83608 CHU de Nice - Hôpital Saint Roch Nice, France, 06000 收起 << |
NCT03705442 | Colorectal Cancer Metastatic | Phase 2 | Recruiting | February 9, 2020 | Croatia ... 展开 >> Department of Radiotherapy and Oncology Recruiting Rijeka, Primorsko-goranska, Croatia, 51000 Contact: Marin Golcic, MD 51658391 ext 385 marin.golcic@gmail.com 收起 << |
NCT02323516 | Cancer | Phase 2 | Withdrawn | - | France ... 展开 >> CHU Amiens, France Centre François Baclesse Caen, France, 14076 Centre Hospitalier public du Cotentin Cherbourg, France, 50100 Centre hospitalier Compiegne, France Centre Léon Bérard Lyon, France 收起 << |
NCT02217982 | - | Terminated(Study did not meet ... 展开 >>required enrollment numbers) 收起 << | - | - | |
NCT02008565 | Fecal Incontinence | Phase 3 | Completed | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, California University of California at San Diego La Jolla, California, United States, 92037-0974 Kaiser San Diego San Diego, California, United States, 92110 United States, New Mexico University of New Mexico Albuquerque, New Mexico, United States, 87131 United States, North Carolina Duke University Durham, North Carolina, United States, 27707 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19118 University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Rhode Island Brown/Women and Infants Hospital of Rhode Island Providence, Rhode Island, United States, 02903 收起 << |
NCT02143921 | Acute Childhood Diarrhea | Not Applicable | Completed | - | Bangladesh ... 展开 >> International Centre for Diarrhoeal Disease Research, Bangladesh Dhaka, Bangladesh, 1212 收起 << |
NCT02008565 | - | Completed | - | - | |
NCT02217982 | Relapsing Remitting Multiple S... 展开 >>clerosis 收起 << | Phase 4 | Terminated(Study did not meet ... 展开 >>required enrollment numbers) 收起 << | - | United States, Utah ... 展开 >> Rocky Mountain MS Research Group Salt Lake City, Utah, United States, 84103 收起 << |
NCT02268071 | Hypertension | Not Applicable | Recruiting | March 2022 | France ... 展开 >> Cabinet de groupe Dr Birgé Recruiting Boulay, France, 57220 Contact: Jacques Birgé, Doctor Cabinet de groupe Dr BAUDOIN Recruiting Bouzonville, France, 57320 Contact: Marie-France Baudoin, Doctor Cabinet de groupe Dr Gries Recruiting Dettwiller, France, 67490 Contact: Jean-Luc Gries, Doctor Cabinet du Dr Di Patrizio Recruiting Dombasle Sur Meurthe, France, 54110 Contact: Paolo Di Patrizio, doctor Cabinet médical Dr Bouché Recruiting Dombasle Sur Meurthe, France, 54110 Contact: Pascal Bouché, Doctor Cabinet médical du Dr Chevillard Recruiting Dombasle Sur Meurthe, France, 54110 Contact: Emmanuelle Chevillard, Doctor Maison de santé Dr Millet-Malingrey Recruiting Gondrecourt, France, 55130 Contact: Laurène Millet-Malingrey, Doctor Maison de Santé Pluridisciplinaire de GROSTENQUIN Recruiting Grostenquin, France, 57660 Contact: Jean Luc METZINGER, Doctor Cabinet de groupe Dr Rougerie Recruiting Hatten, France, 67690 Contact: Fabien Rougerie, Doctor Cabinet du Dr Plane Recruiting Jarville La Malgrange, France, 54140 Contact: Philippe Plane, doctor Cabinet médical prof Boivin Recruiting Laxou, France, 54520 Contact: Jean Marc BOIVIN, Prof Cabinet du Dr LARQUE Recruiting Le Palais-sur-Vienne, France, 87410 Contact: Fabrice Larque, doctor Cabinet de groupe Dr Faure Christian Recruiting Limoges, France, 87000 Contact: Christian Faure, Doctor Cabinet Dr Bleynie Recruiting Limoges, France, 87100 Contact: Philippe Bleynie, Doctor Cabinet du Dr Poyeton Recruiting Neufchateau, France, 88300 Contact: Thierry Poyeton, Doctor Cabinet Dr Delage Recruiting Nexon, France, 87800 Contact: Magali Delage, Doctor Contact: Pierre Delage, Doctor Cabinet de groupe Dr Masson, Recruiting Remilly, France, 57580 Contact: Arnaud Masson, Doctor Cabinet de groupe en pôle de santé Recruiting Revigny-sur-Ornain, France, 55800 Contact: Olivier Bouchy, doctor Cabinet du Dr Louyot-Keller Recruiting Saint-Avold, France, 57500 Contact: Jocelyne Louyot-Keller, Doctor Cabinet médical du Dr Carrier Recruiting Saint-Max, France, 54130 Contact: Gérard Carrier, Doctor Maison de Santé du Neuhof Recruiting Strasbourg, France Contact: Juliette CHAMBE, Dr cabinet de groupe Dr Steyer Recruiting Talange, France, 57525 Contact: Elisabeth Steyer, doctor Centre d'Investigation Clinique module plurithématique 1433 Inserm/CHRU de Nancy Recruiting Vandoeuvre Les Nancy, France, 54500 Contact: Jean-Marc Boivin, Professor +33 3 83 15 73 20 cabinet du Dr Gerard Recruiting Vicherey, France, 88170 Contact: Marie France GERARD, doctor 收起 << |
NCT01717456 | Fecal Incontinence | Not Applicable | Terminated(Low enrollment led ... 展开 >>sponsor to terminate study early.) 收起 << | - | United States, North Carolina ... 展开 >> University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599-7080 收起 << |
NCT00685607 | Diarrhea | Phase 4 | Completed | - | Mexico ... 展开 >> Universidad Autonoma de Guadalajara Guadalajara, Jalisco, Mexico, 44100 收起 << |
NCT02266849 | Rectal Cancer ... 展开 >> Ulcerative Colitis Short Bowel Syndrome 收起 << | Phase 3 | Terminated(Insuficcient recrui... 展开 >>ting) 收起 << | - | Denmark ... 展开 >> Odense University Hospital, Surgical Department A Odense, Denmark, 5000 收起 << |
NCT01717456 | - | Terminated(Low enrollment led ... 展开 >>sponsor to terminate study early.) 收起 << | - | - | |
NCT01780909 | Concentration-Time Profiles in... 展开 >> Stomach & Intestine. 收起 << | Not Applicable | Unknown | December 2017 | Belgium ... 展开 >> Gasthuisberg Recruiting Leuven, BE, Belgium, 3000 Sub-Investigator: Jan Tack, PhD MD 收起 << |
NCT00444093 | Diarrhea Ente... 展开 >>ritis Cancer 收起 << | Phase 3 | Terminated(bad recruitment) | - | - |
NCT02242656 | Short Bowel Syndrome ... 展开 >> Short Gut Syndrome SBS Short Bowel Short Gut 收起 << | Phase 3 | Withdrawn(Transfer of IND to n... 展开 >>ew marketing authorization holder) 收起 << | - | United States, Illinois ... 展开 >> Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 Regional Infectious Diseases Infusion Center Lima, Ohio, United States, 45801 United States, Tennessee Vanderbilt Center for Human Nutrition Nashville, Tennessee, United States, 37212-1150 收起 << |
NCT01302093 | Antidiarrheals | Phase 1 | Completed | - | Canada, Quebec ... 展开 >> Algorithme Pharma Inc. Mount-Royal, Quebec, Canada, H3P 3P1 收起 << |
NCT01739634 | Diarrhea Medu... 展开 >>llary Thyroid Cancer 收起 << | Phase 1 Phase 2 | Unknown | December 2013 | United States, Texas ... 展开 >> MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Principal Investigator: Maria E Cabanillas, MD Sub-Investigator: Ramona Dadu, MD 收起 << |
NCT00806299 | Drug Interaction | Phase 1 | Completed | - | United States, North Dakota ... 展开 >> Cetero Research Fargo, North Dakota, United States, 58104 收起 << |
NCT00807326 | Diarrhea | Phase 4 | Completed | - | India ... 展开 >> Manipal Goa Hospital Goa, India, 403004 Vrundavan Hospital & Research Centre Goa, India, 403527 Mexico North West Medical San José del Cabo, Baja California Sur, Mexico, 22447 Dr. Maxwell´s Clinic San Miguel de Allende, Guanuajuato, Mexico, 37700 Hospital Amerimed Puerto Vallarta Puerto Vallarta, Jalisco, Mexico, 48300 Servicios Medicos de la Bahia Puerto Vallarta, Jalisco, Mexico, 48300 收起 << |
NCT02354768 | High Output Stoma | Phase 3 | Terminated | - | France ... 展开 >> Hôpital Jean Minjoz - Service de Chirurgie Digestive Besançon, France, 25030 Hôpitaux Civils de Colmar - Service de Chirurgie Digestive Colmar, France, 68024 Hopital du Bocage - CHU Dijon- Service de Chirurgie Digestive Dijon, France Hôpital Emile MULLER - Service de Chirurgie Digestive Mulhouse, France, 68070 CHU Robert Debré Service de chirurgie générale, digestive et endocrinienne Reims, France, 51100 Hôpital de Hautepierre-Service de Chirurgie Digestive Strasbourg, France, 67098 收起 << |
NCT00748215 | Chemotherapeutic Agent Toxicit... 展开 >>y Colorectal Cancer Diarrhea 收起 << | Phase 2 | Completed | - | United States, Oregon ... 展开 >> CCOP - Columbia River Oncology Program Portland, Oregon, United States, 97225 United States, Texas M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 收起 << |
NCT00003057 | Colorectal Cancer ... 展开 >> Diarrhea 收起 << | Phase 3 | Completed | - | - |
NCT03094052 | HER2-positive Breast Cancer | Phase 2 | Recruiting | December 2, 2020 | United States, California ... 展开 >> UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94115 Contact: Jo Chien 877-827-3222 cancertrials@ucsf.edu Principal Investigator: Jo Chien, MD 收起 << |
NCT00933465 | Fecal Incontinence | Phase 4 | Withdrawn | May 2010 | United Kingdom ... 展开 >> Southampton General Hospital Southampton, Hampshire, United Kingdom, so16 6YD 收起 << |
NCT00778115 | Healthy | Not Applicable | Completed | - | United States, Missouri ... 展开 >> Gateway Medical Research, Inc. St. Charles, Missouri, United States, 63301 收起 << |
NCT01570634 | - | Terminated(Study was stopped f... 展开 >>or slow enrollment - only 2 patients, no evaluable results) 收起 << | - | - | |
NCT02340481 | Diarrhea | Phase 3 | Completed | - | China ... 展开 >> Beijing, China Guangzhou, China Nanjing, China Shanghai, China 收起 << |
NCT01570634 | Diarrhoea, Clostridium Diffici... 展开 >>le 收起 << | Phase 2 | Terminated(Study was stopped f... 展开 >>or slow enrollment - only 2 patients, no evaluable results) 收起 << | - | United States, Texas ... 展开 >> Scott & White Memorial Hospital Temple, Texas, United States, 76508 收起 << |
NCT00387894 | - | Terminated(Insufficient accrua... 展开 >>l of population likely to benefit; progression in 6 patients) 收起 << | - | - | |
NCT00863928 | Pain Management | Not Applicable | Completed | - | United States, Washington ... 展开 >> Virginia Mason Medical Center Seattle, Washington, United States, 98101 收起 << |
NCT00895193 | Hypercholesterolemia ... 展开 >> Flushing 收起 << | Not Applicable | Completed | - | United States, Kansas ... 展开 >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 收起 << |
NCT00387894 | Adult Brain Tumors | Phase 2 | Terminated(Insufficient accrua... 展开 >>l of population likely to benefit; progression in 6 patients) 收起 << | - | United States, California ... 展开 >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94143 收起 << |
NCT00583323 | Lymphoma | Phase 3 | Completed | - | - |
NCT00895193 | - | Completed | - | - | |
NCT01150474 | - | Completed | - | - | |
NCT01481844 | Optimization of Second Line Tr... 展开 >>eatment Protocol for H Pylori Eradication 收起 << | Phase 3 | Completed | - | Israel ... 展开 >> Soroca UMC Beer-Sheva, Israel 收起 << |
NCT01150474 | Vaginal Surgery | Phase 4 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic Phoenix, Arizona, United States, 85054 收起 << |
NCT01723722 | Neonatal Abstinence Syndrome | Phase 4 | Completed | - | United States, Maine ... 展开 >> Eastern Maine Medical Center Bangor, Maine, United States, 04401 收起 << |
NCT00002682 | Lymphoma | Phase 2 | Completed | - | United States, Florida ... 展开 >> MD Anderson Cancer Center Orlando Orlando, Florida, United States, 32806 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01773096 | Constipation | Phase 4 | Completed | - | United States, Washington ... 展开 >> Shriners Hospitals for Children- Spokane Spokane, Washington, United States, 99203 收起 << |
NCT01756651 | Other Acute Pain ... 展开 >> Pain Experienced During Cystoscopy 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> Urology Clinic, Harbor-UCLA Medical Center Torrance, California, United States, 90502 收起 << |
NCT01831323 | - | Unknown | May 2015 | Italy ... 展开 >> Sant'Eugenio Hospital Recruiting Rome, RM, Italy, 00144 Contact: Gianmarco Giorgetti, MD gianmarcogiorgetti@gmail.com Principal Investigator: Gianmarco Giorgetti, MD 收起 << | |
NCT01832402 | Advanced Cancers | Phase 2 | Active, not recruiting | June 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01723722 | - | Completed | - | - | |
NCT01984138 | Estrogen Receptor Positive Bre... 展开 >>ast Cancer Breast Cancer 收起 << | Phase 2 | Recruiting | September 2019 | United States, Texas ... 展开 >> Lester and Sue Smith Breast Center at Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Claudette Foreman 713-798-1999 caforema@bcm.edu Contact: Brenda Reusser, BA 713-798-1929 breusser@bcm.edu Sub-Investigator: Anuja Vyas, MD Sub-Investigator: Sobia Khan, MD 收起 << |
NCT01967329 | Helicobacter Pylori Infection | Phase 4 | Enrolling by invitation | October 2018 | Canada, Alberta ... 展开 >> University of Alberta Edmonton, Alberta, Canada, T6G 2E1 收起 << |
NCT01742429 | Cure Rate of Helicobacter Pylo... 展开 >>ri Infection 收起 << | Phase 4 | Completed | - | China, Shanghai ... 展开 >> Renji Hospital, Shanghai Jiao-Tong University School of Medicine Shanghai, Shanghai, China, 200127 收起 << |
NCT01980498 | Predictable BTP at Swallowing ... 展开 >>in in Head/Neck Cancer Patients Undergoing Radiotherapy Already Receiving Opioid Therapy for Background Pain 收起 << | Phase 3 | Withdrawn | - | Italy ... 展开 >> Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) Meldola, Forlì - Cesena, Italy, 47014 Azienda Ospedaliera Ospedali Riuniti Marche Nord Pesaro, Pesaro e Urbino, Italy, 61121 Istituto per la Ricerca e la Cura del Cancro a carattere Scientifico - IRCC Candiolo, Torino, Italy, 10060 Azienda Ospedaliera San luigi di Gonzaga di Orbassano Orbassano, Torino, Italy, 10043 Presidio Ospedaliero Mirano Azienda Ulss 13 Mirano, Venezia, Italy, 30035 Ospedale Sacro Cuore- dona Calabria di Negrar Negrar, Verona, Italy, 37024 Ospedale Bellaria Bologna, Italy, 40139 Azienda Ospedaliera "Spedali civili" di Brescia Brescia, Italy, 25123 Ospedale Santa Croce e Carlè Cuneo, Italy, 12100 Azienda Ospedaliera universitaria Careggi Firenze, Italy, 50134 IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro Genova, Italy, 16132 Ospedale Carlo Poma Mantova, Italy, 46100 Ospedale San Raffaele Milano, Italy, 20132 Fondazione IRCCS Istituto Nazionale Tumori Milano, Italy, 20133 Istituto Europeo di Oncologia Milano, Italy, 20141 Ospedale Niguarda Ca' Granda Milano, Italy, 20162 Istituto Nazionale Tumori IRCCS - Fondazione Pascale Napoli, Italy, 80131 Azienda Ospedaliero Universitaria Pisana Pisa, Italy, 56100 Istituto Nazionale Tumori Regina Elena Roma, Italy, 00144 Policlinico Universitario Gemelli di Roma Roma, Italy, 00168 Ospedale Santa Maria della Misericordia Rovigo, Italy, 45100 A.O. Città della Salute e della Scienza - Ospedale Dermatologico S. Lazzaro Torino, Italy, 10126 Ospedale di Trento - Presidio Ospedaliero Santa Chiara Trento, Italy, 38122 Azienda ULSS 9 Presidio Ospedaliero di Treviso Treviso, Italy, 31100 Azienda U.L.S.S. 12 Veneziana Venezia Mestre, Italy 收起 << |
NCT01915901 | Healthy | Phase 1 | Completed | - | United States, Florida ... 展开 >> Research Site Daytona Beach, Florida, United States, 32117 United States, Texas Research Site Dallas, Texas, United States, 75247 United States, Wisconsin Research Site Madison, Wisconsin, United States, 53704 收起 << |
NCT02050503 | - | Completed | - | Spain ... 展开 >> Alejandro de la Torre. Hospital Puerta de Hierro Majadahonda, Madrid, Spain, 28220 收起 << | |
NCT02371473 | Central Sleep Apnea, Secondary | Phase 4 | Enrolling by invitation | December 2018 | Iran, Islamic Republic of ... 展开 >> Masih Daneshvari Hospital Tehran, Iran, Islamic Republic of, 19569-44413 收起 << |
NCT02516202 | - | Completed | - | - | |
NCT02502175 | Opioid Dependence | Phase 3 | Recruiting | July 2018 | Iran, Islamic Republic of ... 展开 >> Dodange Substance use disorder treatment center Recruiting Mohammadabad, Mazandaran, Iran, Islamic Republic of Contact: Ali Gholami +98911 112 2453 Kian substance use treatment center Recruiting Sari, Mazandaran, Iran, Islamic Republic of Contact: Ali Gholami, MD +989111122453 Tavalodi Digar Recruiting Isfahan, Iran, Islamic Republic of Contact: Reza Givaki, MD +98913 212 0871 Rooz-e-No substance use treatment center Recruiting Shiraz, Iran, Islamic Republic of Contact: Saeed Tavakoli, MD dr.saeed.t@gmail.com 收起 << |
NCT02516202 | Atrophy of Vagina ... 展开 >> Menopause Dyspareunia (Female) 收起 << | Phase 3 | Completed | - | United States, Minnesota ... 展开 >> University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Washington Kaiser Permanente Washington Health Research Institute Seattle, Washington, United States, 98101 收起 << |
NCT02977286 | Constipation | Phase 4 | Recruiting | July 2018 | United States, Massachusetts ... 展开 >> Tufts Medical Center Recruiting Boston, Massachusetts, United States, 02111 Contact: John W Devlin, PharmD 617-636-6124 jdevlin@tuftsmedicalcenter.org Contact: Erik Garpestad, MD 6176362362 egarpestad@tuftsmedicalcenter.org 收起 << |
NCT02988089 | Helicobacter Pylori Infection ... 展开 >> Antimicrobial Susceptibility Testing 收起 << | Phase 4 | Recruiting | September 2017 | China, Shandong ... 展开 >> Department of Gastroenterology, Qilu Hospital, Shandong University Recruiting Ji'nan, Shandong, China, 250012 Contact: Yanqing Li, MD, PhD 86-531-82169236 liyanqing@sdu.edu.cn Contact: Yanqing Li, MD, PhD 86-0531-82169236 liyanqing@sdu.edu.cn 收起 << |
NCT03332056 | Nephrolithiasis | Phase 4 | Completed | - | - |
NCT03198767 | Obesity | Phase 2 | Completed | - | United States, Nebraska ... 展开 >> Novartis Investigative Site Lincoln, Nebraska, United States, 68502 收起 << |
NCT02865395 | Overactive Bladder | Phase 4 | Terminated(Another study publi... 展开 >>shed with similar results) 收起 << | - | United States, District of Col... 展开 >>umbia George Washington University Washington, District of Columbia, United States, 20037 收起 << |
NCT03370848 | Flushing Hype... 展开 >>rlipidemias Dyslipidemias 收起 << | Phase 4 | Completed | - | United States, California ... 展开 >> VA West Los Angeles Medical Center Los Angeles, California, United States, 90073 收起 << |
NCT03565484 | Helicobacter Pylori Infection | Phase 4 | Not yet recruiting | April 30, 2020 | China, Shandong ... 展开 >> Qilu hosipital Not yet recruiting Jinan, Shandong, China, 257000 Contact: Xiuli Zuo, MD,PhD 15588818685 ext 053188369277 zuoxiuli@sina.com Sub-Investigator: Chaoran Ji, MD Sub-Investigator: Jing Liu, MD 收起 << |
NCT03616405 | Helicobacter Pylori Infection | Phase 4 | Not yet recruiting | June 30, 2019 | China, Shandong ... 展开 >> Xiuli Zuo Jinan, Shandong, China 收起 << |
NCT03658733 | Helicobacter Pylori Infection | Phase 4 | Not yet recruiting | October 31, 2019 | China, Shandong ... 展开 >> Xiuli Zuo Recruiting Jinan, Shandong, China Contact: Xiuli Zuo, PhD,MD 15588818685 ext 053188369277 zuoxiuli@sina.com Sub-Investigator: Yue Li, MD Sub-Investigator: Chaoran Ji, MD 收起 << |
NCT03198767 | - | Completed | - | - | |
NCT03757650 | Helicobacter Pylori Infection ... 展开 >> Obesity, Morbid 收起 << | Phase 4 | Active, not recruiting | February 1, 2020 | Turkey ... 展开 >> Fatih Sultan Mehmet Research and Training Hospital Istanbul, Turkey, 34734 收起 << |
NCT03658746 | Helicobacter Pylori Infection | Phase 4 | Not yet recruiting | April 30, 2020 | China, Shandong ... 展开 >> Qilu hosipital Jinan, Shandong, China, 257000 收起 << |
NCT03571230 | Helicobacter Pylori Infection ... 展开 >> Antimicrobial Susceptibility Testing 收起 << | Phase 4 | Not yet recruiting | January 30, 2020 | China, Shandong ... 展开 >> Xiuli Zuo Not yet recruiting Jinan, Shandong, China Contact: Xiuli Zuo, PhD,MD 15588818685 ext 053188369277 zuoxiuli@sina.com Sub-Investigator: Jing Liu, MD Sub-Investigator: Chaoran Ji, MD 收起 << |
NCT02016807 | - | Unknown | January 2015 | United States, Rhode Island ... 展开 >> Translational Medicine Research Center Foster, Rhode Island, United States, 02825 收起 << | |
NCT02299466 | - | Recruiting | December 2021 | Canada, Alberta ... 展开 >> Foothills Medical Centre Recruiting Calgary, Alberta, Canada Contact: Maitreyi Raman, MD 403-943-2580 mkothand@ucalgary.ca Contact: Sari Czink, RD 403-944-1638 Sari.czink@calgaryhealthregion.ca Captial Health/University Of Alberta Recruiting Edmonton, Alberta, Canada Contact: Leah Gramlich, MD 780-735-6839 eah.gramlich@ualberta.ca Contact: Holly Ames, RD 780-407-6021 holly.ames@albertahealthservices.ca Canada, British Columbia BC Home Parenteral Nutrition Program Recruiting Vancouver, British Columbia, Canada Contact: Scott Whittaker, MD 604-688-6332 x226 scottwhittaker@mac.com Contact: Holly van Heukelom 604-806-9808 HvanHeukelom@providencehealth.bc.ca Canada, Manitoba St. Boniface General Hospital Recruiting Winnipeg, Manitoba, Canada, R2H 2A6 Contact: Donald Duerksen, MD dduerkse@sbgh.mb.ca Canada, Ontario Hamilton Health Sciences Recruiting Hamilton, Ontario, Canada Contact: David Armstrong, MD armstro@mcmaster.ca Contact: Suzanne Hansen, RD 905-521-2100 ext 75358 shansen@hhsc.ca St. Michael's Hospital Recruiting Toronto, Ontario, Canada Contact: Khursheed Jeejeebhoy, MD 416-864-5348 khushjeejeebhoy@compuserve.com Contact: Brian Jurewitsch, RN 416.864.5431 jurewitschb@smh.toronto.on.ca Canada, Quebec Hopital St-Luc Recruiting Montréal, Quebec, Canada, H2X 0C1 Contact: Louise D'Aoust, MD 514-890-8000 louise_daoust@sympatico.ca McGill University Recruiting Montréal, Quebec, Canada, H3G 1A4 Contact: Errol Marliss, MD 514) 843-1665 marliss.errol@muhc.mcgill.ca Contact: Sylvie LeBourdias, RN 514-934-1934 ext 35392 Sylvie.Lebourdais@muhc.mcgill.ca Hotel-Dieu de Quebec Recruiting Québec, Quebec, Canada Contact: Marie-France Boudreault, RN 418-525-4444 marie-france.boudreault@chuq.qc.ca Canada, Saskatchewan Saskatchewan Adult HTPN Program Recruiting Regina, Saskatchewan, Canada, S4T 1A5 Contact: Danielle Stevenson, RN +1-306-766-2746 Danielle.Stevenson@rqhealth.ca 收起 << | |
NCT03657407 | Hysterectomy ... 展开 >>Pain, Postoperative 收起 << | Phase 4 | Completed | - | United States, Maryland ... 展开 >> Mercy Medical Center Baltimore, Maryland, United States, 21202 收起 << |
NCT01318993 | Crohn's Disease | Phase 3 | Terminated(This study was term... 展开 >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) 收起 << | - | - |
NCT01318993 | - | Terminated(This study was term... 展开 >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) 收起 << | - | - | |
NCT01474499 | Constipation | Phase 3 | Completed | - | China, Guangdong ... 展开 >> Southern Medical University - Nanfang Hospital Guangzhou, Guangdong, China The First Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China The Second Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China China, Hubei Zhongnan Hospital of Wuhan University Wuhan, Hubei, China China, Jiangsu Nanjing First Hospital Nanjing, Jiangsu, China The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China China, Shanghai Shanghai Changhai Hospital Shanghai, Shanghai, China Shanghai Jiaotong University Medical School - Renji Hospital Shanghai, Shanghai, China Shanghai Jiaotong University Medical School - Ruijin Hospital Shanghai, Shanghai, China 收起 << |
NCT03017430 | Opioid Withdrawal | Phase 4 | Recruiting | December 2019 | Russian Federation ... 展开 >> St.-Petersburg Bekhterev Reserach Psychoneurological Institute Recruiting St.-Petersburg, Russian Federation, 192019 Contact: Evgeny M Krupitsky, MD, PhD +7-911-748-9989 kruenator@gmail.com Sub-Investigator: Ruslan D Ilyuk, MD 收起 << |
NCT02057133 | Breast Neoplasms | Phase 1 | Recruiting | December 16, 2020 | United States, Arkansas ... 展开 >> Highlands Oncology Group Recruiting Fayetteville, Arkansas, United States, 72703 Contact 479-587-1700 Principal Investigator: Joseph T Beck United States, California University of California - San Diego Recruiting La Jolla, California, United States, 92037-0845 Contact 858-246-4777 Principal Investigator: Teresa Helsten United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact 617-632-5869 Principal Investigator: Sara M Tolaney United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905-0002 Contact 507-266-6264 Principal Investigator: Matthew P Goetz United States, New York Columbia University College of Phys & Surgeons Completed New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact 646-888-5145 Principal Investigator: Komal Jhaveri United States, North Carolina University of North Carolina at Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27514 Contact 919-843-7714 Principal Investigator: E. Claire Dees United States, Ohio Peggy and Charles Stephenson Oklahoma Cancer Center Recruiting Oklahoma City, Ohio, United States, 73104 Contact 4052717770 Principal Investigator: Kathleen Moore United States, Oregon Providence Cancer Center Oncology Hematology Care Recruiting Portland, Oregon, United States, 97213 Contact 506-216-8636 Principal Investigator: Alison Conlin United States, Pennsylvania Univ of Pittsburgh Cancer Inst. (UPCI) Completed Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee Sarah Cannon Cancer Center Recruiting Nashville, Tennessee, United States, 37203 Contact 615-327-7212 Principal Investigator: SMO Sarah Cannon Research Inst. Tennessee Oncology PLLC Recruiting Nashville, Tennessee, United States, 37203 Contact 615-329-7274 Principal Investigator: Howard A. Burris III Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232-6307 Contact 615-936-3524 Principal Investigator: Brent N Rexer United States, Texas Texas Oncology-Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States, 75246 Contact 214-370-1949 Principal Investigator: Carlos H Becerra South Texas Accelerated Research Therapeutics, LLC Recruiting San Antonio, Texas, United States, 78229-3307 Contact 210-593-5250 Principal Investigator: Muralidhar Beeram US Oncology Active, not recruiting The Woodlands, Texas, United States, 77380 收起 << |
NCT00650637 | Diarrhea | Phase 3 | Terminated(The study was prema... 展开 >>turely discontinued due to administrative reasons on August 18, 2003. There were no safety concerns that led to the decision to terminate.) 收起 << | - | United States, Alabama ... 展开 >> Pfizer Investigational Site Birmingham, Alabama, United States, 35233 United States, Florida Pfizer Investigational Site Ft. Lauderdale, Florida, United States, 33308 United States, New York Pfizer Investigational Site New York, New York, United States, 10011 United States, North Carolina Pfizer Investigational Site Huntersville, North Carolina, United States, 28078 United States, Texas Pfizer Investigational Site Austin, Texas, United States, 78705 Pfizer Investigational Site Houston, Texas, United States, 77098 收起 << |
NCT00799201 | Constipation ... 展开 >>Analgesia 收起 << | Phase 4 | Terminated(Naloxone became una... 展开 >>vailable due to manufacturing shortatges requiring the study to be terminated.) 收起 << | - | United States, West Virginia ... 展开 >> Charleston Area Medical Center, General Hospital Charleston, West Virginia, United States, 25301 收起 << |
NCT01954030 | Malignant Glioma (WHO Grade II... 展开 >>I or IV) 收起 << | Phase 1 | Terminated(Study terminated ea... 展开 >>rly due to funding reasons prior to completing Phase 1) 收起 << | - | United States, North Carolina ... 展开 >> The Preston Robert Tisch Brain Tumor Center at Duke Durham, North Carolina, United States, 27710 收起 << |
NCT01925274 | Metastatic Colorectal Cancer | Phase 2 | Terminated(Enrollment to the s... 展开 >>tudy was terminated on 11Nvo2014 due to slow recruitment. There were no safety or efficacy issues that contributed to this decision.) 收起 << | - | United States, California ... 展开 >> CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309 Drug Management Only: UCLA West Medical Pharmacy, Att: Steven L Wong, Pharm D Los Angeles, California, United States, 90095-7349 Drug Management Only: UCLA West Medical Pharmacy Los Angeles, California, United States, 90095-7349 UCLA West Medical Pharmacy Los Angeles, California, United States, 90095-7349 Regulatory Management Only: TRIO-US Central Administration Los Angeles, California, United States, 90095 TRIO-US Central Administration (Regulatory Management only) Los Angeles, California, United States, 90095 TRIO_US Los Angeles, California, United States, 90095 West Valley Hematology/Oncology Med Group Northridge, California, United States, 91328 United States, Missouri Siteman Cancer Center - West County Creve Coeur, Missouri, United States, 63141 Barnes-Jewish Hospital Saint Louis, Missouri, United States, 63110 Drug Shipping Address: Washington University Infusion Center Pharmacy Saint Louis, Missouri, United States, 63110 Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Siteman Cancer Center - South County Saint Louis, Missouri, United States, 63129 Siteman Cancer Center - St Peters Saint Peters, Missouri, United States, 63376 United States, Nevada Regulatory Office: Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89014 Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89052 Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89074 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89128 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89148 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89169 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Washington Kadlec Clinic Hematology and Oncology Kennewick, Washington, United States, 99336 Kadlec Medical Center Richland, Washington, United States, 99352 Outpatient Imaging Center Richland, Washington, United States, 99352 Spokane Valley Cancer Center Spokane Valley, Washington, United States, 99216 Medical Oncology Associates, PS Spokane, Washington, United States, 99208 Japan Aichi cancer center central hospital Nagoya, Aichi, Japan, 464-8681 National Cancer Center Hospital East Kashiwa, Chiba, Japan, 277-8577 Korea, Republic of National Cancer Center Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Seoul National University Hospital / Department of Internal Medicine Seoul, Korea, Republic of, 110-744 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Asan Medical Center Seoul, Korea, Republic of, 138-736 Spain Hospital General Universitario Gregorio Marañón Madrid, Spain, 28009 收起 << |
NCT01106352 | Bone Metastases ... 展开 >> Castration-Resistant Prostate Cancer 收起 << | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> San Francisco, California, United States, 94115 United States, Illinois Evanston, Illinois, United States, 60201 United States, Maryland Baltimore, Maryland, United States, 21287 United States, Massachusetts Boston, Massachusetts, United States, 02115-6013 United States, New York New York, New York, United States, 10065 United States, Washington Seattle, Washington, United States, 98109 France Villejuif Cedex, France, 94805 收起 << |
NCT02505568 | Behcet Disease | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Busan, Korea, Republic of Daegu, Korea, Republic of Gangwon-Do, Korea, Republic of Gyeonggi-Do, Korea, Republic of Seoul, Korea, Republic of 收起 << |
NCT03706456 | Complex Perianal Fistulas in A... 展开 >>dult Patients With Crohn's Disease 收起 << | Phase 3 | Not yet recruiting | November 30, 2022 | - |
NCT01941316 | Small Cell Lung Carcinoma ... 展开 >> Non Small Cell Lung Carcinoma Irinotecan Sensitive Cancers 收起 << | Phase 1 Phase 2 | Recruiting | December 2018 | United States, Arizona ... 展开 >> Cancer Treatment Centers of America, Western Regional Medical Center Completed Goodyear, Arizona, United States, 85338 United States, California Cedars-Sinai Medical Center Withdrawn Los Angeles, California, United States, 90048 UCLA Withdrawn Santa Monica, California, United States, 90404 United States, Kentucky University of Kentucky Markey Cancer Center Recruiting Lexington, Kentucky, United States, 40536 Contact: Susanne M Arnold, MD 859-323-8043 smarno0@uky.edu Principal Investigator: Susanne M Arnold, MD Norton Cancer Institute Recruiting Louisville, Kentucky, United States, 40202 Contact: John Hamm, MD 502-629-1234 John.hamm@nortonhealthcare.org Principal Investigator: John Hamm, MD United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Maria Baggstrom, MD MBaggstr@DOM.wustl.edu Contact: Kristina Williams (314) 362-6963 kjwillia1@im.wustl.edu Principal Investigator: Maria Baggstrom, MD United States, Oregon Providence Portland Medical Center | Earle A. Chiles Research Institute Recruiting Portland, Oregon, United States, 97213 Contact: Rachel E Sanborn, MD 503-215-5696 Rachel.Sanborn@providence.org Principal Investigator: Rachel E Sanborn, MD United States, Texas University of Texas Medical Branch at Galveston Recruiting Galveston, Texas, United States, 77555 Contact: Steven P Rivas 409-772-0574 sprivas@utmb.edu Contact: Nakia Watson 409-772-0575 nawatson@utmb.edu Principal Investigator: Maurice Willis, MD United States, Washington Virginia Mason Cancer Institute Recruiting Seattle, Washington, United States, 98111 Contact: Emma Bishop 206-341-8979 emma.bishop@virginiamason.org Principal Investigator: Joseph Rosales, MD United States, Wisconsin Aurora Research Institute | Aurora Cancer Care Recruiting Wauwatosa, Wisconsin, United States, 53226 Contact: Michael Thompson, MD, PhD 414-219-7838 Michael.A.Thompson@aurora.org Principal Investigator: Michael Thomson, MD, PhD 收起 << |
NCT00098345 | - | Completed | - | - | |
NCT01106352 | - | Completed | - | - | |
NCT00098345 | Thyroid Cancer | Phase 2 | Completed | - | United States, California ... 展开 >> Research Site San Francisco, California, United States United States, Connecticut Research Site New Haven, Connecticut, United States United States, New York Research Site New York, New York, United States United States, North Carolina Research Site Durham, North Carolina, United States United States, Texas Research Site Houston, Texas, United States France Research Site Villejuif Cedex, France 收起 << |
NCT01925274 | - | Terminated(Enrollment to the s... 展开 >>tudy was terminated on 11Nvo2014 due to slow recruitment. There were no safety or efficacy issues that contributed to this decision.) 收起 << | - | - | |
NCT01618591 | Acute Watery Diarrhea ... 展开 >> Dysentery/Febrile Diarrhea 收起 << | Not Applicable | Terminated(AWD arm was complet... 展开 >>ed. ADF diarrhea arm was unable to fill completely and there are no funds remaining to continue recruiting/enrolling.) 收起 << | - | Afghanistan ... 展开 >> UK Role 3 Joint Force Hospital Camp Bastion, Afghanistan Djibouti U.S. Naval Expeditionary Base Camp Lemonnier, Djibouti Honduras Joint Task Force - Bravo Soto Cano Air Base, Honduras Kenya British Army Training Unit Kenya Nanyuki, Kenya Thailand Armed Forces Research Institute of Medical Sciences Bangkok, Thailand 收起 << |
NCT00326599 | Lung Cancer | Phase 2 | Completed | - | - |
NCT01989052 | Malignant Glioma (WHO Grade II... 展开 >>I or IV) 收起 << | Phase 1 | Terminated(This study was term... 展开 >>inated early due to funding issues prior to completion of phase I) 收起 << | - | United States, North Carolina ... 展开 >> The Preston Robert Tisch Brain Tumor Center at Duke Durham, North Carolina, United States, 27710 收起 << |
NCT03006198 | - | Active, not recruiting | December 1, 2018 | Algeria ... 展开 >> Alger, Algeria Egypt Alexandria, Egypt Cairo, Egypt Kuwait Hawalli Area, Kuwait Kuwait, Kuwait Qatar Doha, Qatar Saudi Arabia Makkah, Saudi Arabia Riyadh, Saudi Arabia 收起 << | |
NCT00326599 | - | Completed | - | - | |
NCT01252524 | Diabetes Mellitus Type II | Not Applicable | Completed | - | United States, North Carolina ... 展开 >> East Carolina University Family Medicine Center Greenville, North Carolina, United States, 27834 收起 << |
NCT03670043 | Type2 Diabetes Mellitus | Phase 4 | Not yet recruiting | November 2020 | - |
NCT03592082 | Clostridium Difficile Infectio... 展开 >>n 收起 << | Phase 4 | Withdrawn(Investigator left in... 展开 >>stitution) 收起 << | - | United States, New York ... 展开 >> Bassett Healthcare Network Cooperstown, New York, United States, 13326 收起 << |
NCT01577043 | Acute Diarrhea ... 展开 >> Acute Gastroenteritis 收起 << | Phase 4 | Completed | - | Bolivia ... 展开 >> Centro Pediatrico Albina de Patino Cochabamba, Bolivia 收起 << |
NCT01948011 | Healthy Male Volunteers | Phase 1 | Completed | - | France ... 展开 >> Eurofins Optimed Gières, France, 38610 收起 << |
NCT03473561 | Diarrhea, Infantile | Phase 3 | Recruiting | September 1, 2019 | Taiwan ... 展开 >> Chang Gung Children's Hospital Recruiting Taipei, Taiwan Contact: Cheng-Hsun Chiu, Dr 收起 << |
NCT00583531 | Pouchitis | Phase 2 | Terminated(Lack of enrollment) | - | United States, Minnesota ... 展开 >> Mayo Clinic, Inflammatory Bowel Disease Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT02919670 | Multiple Myeloma ... 展开 >> Non-Hodgkin's Lymphoma 收起 << | Phase 2 | Active, not recruiting | April 2024 | United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT01388647 | - | Terminated(Closed early due to... 展开 >> increased hematologic toxicity and possible reduced efficacy) 收起 << | - | - | |
NCT00583076 | Pouchitis | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Cleveland Clinic Cleveland, Ohio, United States, 44195 收起 << |
NCT01388647 | HER-2 Positive Breast Cancer | Phase 1 Phase 2 | Terminated(Closed early due to... 展开 >> increased hematologic toxicity and possible reduced efficacy) 收起 << | - | United States, Florida ... 展开 >> Holy Cross Hospital Fort Lauderdale, Florida, United States, 33308 United States, Georgia Northeast Georgia Cancer Care Athens, Georgia, United States, 30607 Northwest Georgia Oncology Centers Marietta, Georgia, United States, 30060 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 收起 << |
NCT03463512 | Diarrhea | Phase 3 | Completed | - | Russian Federation ... 展开 >> Saint Petersburg State Budgetary Healthcare Institution "Municipal Outpatient Children Unit #45" Saint Petersburg, Russian Federation 收起 << |
NCT01920607 | Fecal Incontinence ... 展开 >> Anal Incontinence 收起 << | Not Applicable | Suspended(recruitment difficul... 展开 >>ties) 收起 << | August 2017 | France ... 展开 >> Nantes University Hospital Nantes, France, 4000 收起 << |
NCT00591357 | Antibiotic-Associated Diarrhea... 展开 >> Clostridium Difficile 收起 << | Phase 4 | Suspended(Lack of personnel to... 展开 >> complete trial) 收起 << | - | United States, Texas ... 展开 >> VAMC Houston, Texas, United States, 77030 收起 << |
NCT01668147 | Drug Effects | Not Applicable | Completed | - | United States, Missouri ... 展开 >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 收起 << |
NCT01235689 | Crohn's Disease | Phase 3 | Completed | - | - |
NCT01470599 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT01235689 | - | Completed | - | - | |
NCT01644097 | Diarrhea Unsp... 展开 >>ecified Adult Solid Tumor, Protocol Specific 收起 << | Phase 2 | Withdrawn(issues with obtainin... 展开 >>g study product) 收起 << | - | United States, California ... 展开 >> Stanford University Stanford, California, United States, 94305 收起 << |
NCT01470599 | - | Completed | - | - | |
NCT03566407 | Crohn's Disease | Not Applicable | Recruiting | December 2020 | United States, Connecticut ... 展开 >> Medical Research Center of Connecticut, LLC Recruiting Hamden, Connecticut, United States, 06518 Contact: Study Coordinator Principal Investigator: Philip Ginsburg, MD United States, Georgia Atlanta Gastroenterology Associates, LLC Recruiting Atlanta, Georgia, United States, 30309 Contact: Study Coordinator Principal Investigator: Douglas Wolf, MD United States, Louisiana Gastroenterology Associates, LLC Recruiting Baton Rouge, Louisiana, United States, 70809 Contact: Study Coordinator Principal Investigator: Jonathon C Chapman, MD United States, Massachusetts Commonwealth Clinical Studies Recruiting Brockton, Massachusetts, United States, 02302 Contact: Study Coordinator Principal Investigator: Jerry Stern, MD United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Study Coordinator Principal Investigator: Andres Yarur, MD 收起 << |
NCT02215096 | Cancer | Phase 1 | Recruiting | December 2, 2019 | United States, California ... 展开 >> GSK Investigational Site Completed Duarte, California, United States, 91010 GSK Investigational Site Completed Los Angeles, California, United States, 90089 GSK Investigational Site Recruiting Los Angeles, California, United States, 90095 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, District of Columbia GSK Investigational Site Recruiting Washington, District of Columbia, United States, 20007 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Michigan GSK Investigational Site Recruiting Detroit, Michigan, United States, 48201 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, New York GSK Investigational Site Completed New York, New York, United States, 10016 United States, Texas GSK Investigational Site Recruiting Houston, Texas, United States, 77030 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Utah GSK Investigational Site Terminated Salt Lake City, Utah, United States, 84112-5550 United Kingdom GSK Investigational Site Recruiting London, United Kingdom, SE1 9RT Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Sutton, United Kingdom, SM2 5PT Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT00277147 | Typhoid Fever | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01700400 | Non Small Cell Lung Cancer | Phase 1 | Completed | - | United States, Arizona ... 展开 >> University of Arizona Cancer Center Tuscon, Arizona, United States, 85724 United States, Kentucky University of Kentucky Markey Cancer Center Lexington, Kentucky, United States, 40536 United States, Oregon Providence Cancer Center Portland, Oregon, United States, 97213 United States, Washington Cancer Research And Biostatistics Clinical Trials Consortium Seattle, Washington, United States, 98101 收起 << |
NCT01691742 | Post Procedural Constipation | Not Applicable | Completed | - | United States, North Carolina ... 展开 >> Duke University, Department of Urogynecology Durham, North Carolina, United States, 27707 收起 << |
NCT03535272 | Diarrhea Travelers ... 展开 >> Antibiotic Resistant Infection 收起 << | Phase 3 | Recruiting | December 31, 2019 | United States, New York ... 展开 >> New York Center for Travel and Tropical Medicine Recruiting New York, New York, United States, 10022 Contact: Olga Whyte, RN Principal Investigator: Bradley Connor, MD 收起 << |
NCT03710486 | - | Not yet recruiting | October 31, 2019 | - | |
NCT02251119 | Healthy | Phase 1 | Completed | - | - |
NCT01738607 | Fecal Incontinence | Not Applicable | Completed | - | United States, Minnesota ... 展开 >> University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01759264 | - | Completed | - | - | |
NCT01879605 | Constipation ... 展开 >>Ileus Surgery 收起 << | Phase 4 | Completed | - | Norway ... 展开 >> Oslo Universitetssykehus Oslo, Norway, 0424 收起 << |
NCT00401388 | Chondrosarcomas ... 展开 >> Alveolar Soft Part Sarcomas Extra Skeletal Myxoid Chondrosarcomas 收起 << | Phase 2 | Completed | - | - |
NCT02441946 | - | Completed | - | - | |
NCT01759264 | - | Completed | - | - | |
NCT02441946 | Breast Cancer ... 展开 >> Hormone Receptor Positive Tumor Early-Stage Breast Carcinoma 收起 << | Phase 2 | Completed | - | - |
尊敬的 Ambeed 客户您好,
请您选择所在区域,我们将转接对应客服为您服务!